| Trial registration number
|
NCT04792021 |
Full text link
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
https://clinicaltrials.gov/show/NCT04792021
|
First author
Last imported at : April 29, 2022, 3:30 a.m.
Source : ClinicalTrials.gov
|
Sara Mohamed Sherkawy
|
Contact
Last imported at : April 29, 2022, 3:30 a.m.
Source : ClinicalTrials.gov
|
Not reported
|
Registration date
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2021-03-10
|
Recruitment status
Last imported at : April 29, 2022, 3:30 a.m.
Source : ClinicalTrials.gov
|
Completed
|
Study design
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
RCT
|
Allocation
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Randomized
|
Design
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Parallel
|
Masking
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Blind label
|
Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov
|
single-center
|
Study aim
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Treatment
|
Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
inclusion criteria:
adults aged more than 18 years
documented covid-19 infection (either performed on site or documented external report), only moderate cases will be included
|
Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov
|
known allergy or hypersensitivity to nac
pregnancy
critically ill or mechanically ventilated patients
|
Number of arms
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
2
|
Funding
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Ain Shams University
|
Inclusion age min
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
18
|
Inclusion age max
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
100
|
Countries
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Egypt
|
Type of patients
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
60
|
primary outcome
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Change in TNF alfa level from baseline
|
Notes
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
None
|
Phase
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
Phase 3
|
Arms
Last imported at : March 12, 2021, 12:31 a.m.
Source : ClinicalTrials.gov
|
[{"arm_notes": "", "treatment_id": 850, "treatment_name": "N-acetylcysteine", "treatment_type": "Respiratory agents", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]
|